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Abstract
Background: Antibiotics are frequently prescribed for older adults who reside in long-term care
facilities. A substantial proportion of antibiotic use in this setting is inappropriate. Antibiotics are
often prescribed for asymptomatic bacteriuria, a condition for which randomized trials of antibiotic
therapy indicate no benefit and in fact harm. This proposal describes a randomized trial of
diagnostic and therapeutic algorithms to reduce the use of antibiotics in residents of long-term care
facilities.
Methods: In this on-going study, 22 nursing homes have been randomized to either use of
algorithms (11 nursing homes) or to usual practise (11 nursing homes). The algorithms describe
signs and symptoms for which it would be appropriate to send urine cultures or to prescribe
antibiotics. The algorithms are introduced by inservicing nursing staff and by conducting one-on-
one sessions for physicians using case-scenarios. The primary outcome of the study is courses of
antibiotics per 1000 resident days. Secondary outcomes include urine cultures sent and antibiotic
courses for urinary indications. Focus groups and semi-structured interviews with key informants
will be used to assess the process of implementation and to identify key factors for sustainability.
Background
Antibiotic use in long-term care facilities
Antibiotics are frequently prescribed for older adults who
reside in long-term care facilities (LTCFs). The reported
prevalence of antibiotic use in nursing home residents
ranges from 8% to 17% [1–4]. Prospective studies of anti-
biotic use in these facilities demonstrate that 50% to 75%
of residents are exposed to at least one course of antibiot-
ics over a one year period [5–8]. There are several impor-
tant risks associated with the use of antibiotics in residents
of LTCFs [9,10]. First, there is the risk of developing multi-
drug antibiotic resistance with exposure to antibiotics
[11–16]. Second, there is the risk of drug-related adverse
effects. In a study of antibiotic use in Ontario facilities
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which provide chronic care, 6% of individuals developed
an adverse effect [17]. Because polypharmacy in this pop-
ulation is common [18–20], the risk for harmful drug in-
teractions in addition to adverse reactions to antibiotics is
high [9]. Third, the increased use of antibiotics in LTCFs
results in significant costs. In a study of antibiotic use in
Manitoba nursing homes for example, over $257,000 was
spent on antibiotics in the 1988–89 fiscal year for 1000
nursing home residents [7]. Clearly, optimizing the use of
antibiotics in this population is an important quality of
care priority.
Antibiotics for urinary indications
Urinary tract infections are the most common indication
for prescribing antibiotics for residents in LTCFs. Urinary
tract infections alone account for 30% to 56% of all pre-
scriptions for antibiotics in that population [3,4,7,8,20].
The diagnosis of UTIs, like respiratory and other infec-
tions in residents of LTCFs, is difficult [9]. Clinical symp-
toms and signs in this population are often vague and
non-specific. In the absence of valid diagnostic criteria, it
is difficult to develop a strategy to optimize antibiotic use
in the institutionalized elderly. Asymptomatic bacteriuria,
or the presence of bacteria in the urine in the absence of
urinary symptoms, is however an important exception.
This condition occurs in up to 50% of older institutional-
ized women and 35% of institutionalized older men [21–
27]. It is important to note that the term "asymptomatic"
includes bacteriuria in the presence of non-specific, non-
urinary symptoms (e.g. malaise, fatigue, functional
change) [28]. It is recommended that asymptomatic bac-
teriuria be treated in populations at high risk of develop-
ing subsequent infection, such as children or pregnant
women. However, there is compelling evidence to sup-
port not treating asymptomatic bacteriuria in residents of
long-term care facilities. Data from four randomized con-
trolled trials demonstrate a lack of benefit from treating
asymptomatic bacteriuria [23,24,26,28]. These trials, con-
ducted in part to validate the finding of an association be-
tween asymptomatic bacteriuria and death, found no
effect of antibiotic treatment on mortality [29].
Despite clear evidence that supports not treating asympto-
matic bacteriuria, institutionalized older adults are fre-
quently treated for it with antibiotics. It is estimated that
about one third of all prescriptions for urinary indications
in nursing homes are for asymptomatic bacteriuria [3]. In
a 12-month antibiotic utilization in chronic care study,
30% of prescriptions for a urinary indication were for
asymptomatic bacteriuria [17].
Defining "appropriate" antibiotic use for most bacterial
infections is plagued with difficulty due to diagnostic un-
certainties. However, antibiotic prescribing for urinary in-
dications is an important exception. Reducing
inappropriate antibiotic use for urinary indications may
be an important tactic for optimizing the use of antibiot-
ics in LTCFs.
Qualitative study on asymptomatic bacteriuria
To help identify strategies for improving the management
of asymptomatic bacteriuria in older adults in residential
LTCFs, a qualitative study on reasons why antibiotics are
prescribed for this condition was conducted [30]. This
study revealed that ordering urine cultures and prescrib-
ing antibiotics for asymptomatic bacteriuria are largely
driven by nonspecific, non-urinary symptoms (e.g. ma-
laise, confusion, agitation). Nurses, who order urine cul-
tures and influence physicians decision to prescribe
antibiotics, were key in this process. Education and guide-
lines for management of asymptomatic bacteriuria and
urinary tract infection were viewed by study respondents
as an important priority for both physicians and nurses.
Some evidence exists to suggest that systematic practise-
based interventions are effective in changing physician
performance [31]. Therefore, based on the best clinical ev-
idence and our own qualitative data, we have constructed
clinical algorithms for managing UTIs in older adults in
LTCFs.
This paper describes the protocol of an on-going rand-
omized trial to optimize antibiotic use in residents of
nursing homes using clinical algorithms.
Methods
The primary aim of this study is to determine if an evi-
dence-based clinical algorithm for managing urinary tract
infections (UTIs) in older adults in residential long-term
care facilities (LTCFs) can reduce the overall use of antibi-
otics in LTCFs. Secondary study questions include: Does
the use of a diagnostic algorithm reduce the number of
urine cultures ordered for residents in LTCFs without uri-
nary symptoms? Does the use of a treatment algorithm re-
duce the number of antibiotic courses prescribed for
presumptive UTIs in the target population?
Study population
Twenty-two pairs of nursing homes have been enrolled.
Only free standing, community-based residential LTCFs
are eligible. Other eligibility criteria include the following:
1) the facility has 100 or more residents; 2) the LTCF does
not have a stated policy for diagnosis or treatment of uri-
nary tract infections; 3) the LTCF agrees to refrain from in-
troducing new management strategies for antibiotic
utilization or clinical pathways for urinary tract infection
during the study. To enhance representation for residen-
tial LTCFs in the community, the study will be limited to
LTCFs not directly associated with tertiary care centres.BMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/17
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The design is randomized matched pairs (Figure 1). With-
in each of the 11 pairs of LTCFs, one was randomized to
the intervention (clinical algorithm), the other half to
"usual" management. Quantitative outcomes will include
1) the proportion of antibiotic courses prescribed for uri-
nary indications, 2) the total number of courses of antibi-
otics used, 3) rates of urine cultures ordered, 4)
hospitalization rates for urinary tract infections, and 5)
mortality rates. Within a LTCF, randomization of individ-
ual healthcare providers or residents to the algorithm like-
ly would introduce bias due to contamination. Therefore,
for the quantitative component of this study, the nursing
home will serve as the unit of allocation and analysis.
Intervention: an evidence-based clinical algorithm
Although treatment guidelines for infections are abun-
dant in the literature (e.g community-acquired pneumo-
nia) few diagnostic or treatment algorithms for infections
have been systematically evaluated for outcome [32,33]. A
management algorithm for UTIs in nursing homes has
been proposed [34]. However, no algorithms for optimiz-
ing antimicrobial use or for managing infections have
been evaluated in LTCFs. Nursing staff (RNs and RPNs)
play a critical role in the clinical management of LTCF res-
idents. Physicians spend relatively little time at the bed-
side in LTCFs, and must rely heavily on nursing
assessments. Therefore, an intervention to change clinical
practise in LTCFs ideally must 1) be evidence-based, 2) be
feasible to implement, 3) be inexpensive, 4) involve both
nurses and physicians, 5) have the potential for strong
"buy-in" from both physicians and nurses, and 6) be eval-
uable in terms of outcomes. We believe that our clinical
algorithm for the diagnosis and treatment of UTIs in resi-
dents of LTCFs will meet these criteria.
A draft diagnostic and a treatment algorithm was devel-
oped using the best evidence available, augmented with
feedback from primary care physicians and nurses work-
Figure 1
Diagnostic algorithm. This algorithm guides physicians and nurses in the ordering of urine cultures for nursing home residents
with suspected infections.
Diagnostic Pathway
Fever of > 37.9ºC (100 ºF) or 1.5°C (2.4 ºF) increase above baseline
on 2 occasions over the last 12 h ?
2 or more symptoms/signs
of other infection*?
Urinary Catheter ?
Do not order
urine culture
YES
YES
YES
NO
NO
NO
* Respiratory symptoms include increased shortness of breath, increased cough,
increased sputum production, new pleuritic chest pain.
Gastrointestinal symptoms include nausea/vomiting, new abdominal pain, new onset of diarrhea.
Skin/soft tissue symptoms include new redness, warmth, swelling, purulent drainage.
Do I need to order a urine culture for the resident in my care?
Order a urine culture for
new onset burning urination
OR for 2 or more
new or worsening ….
urgency frequency
flank pain gross hematuria
shaking chills suprapubic pain
urinary incontinence
Order a urine culture for 1 or more
of the following:
new onset burning urination (dysuria)
presence of a urinary catheter
new or worsening ….
urgency frequency
flank pain gross hematuria
shaking chills suprapubic pain
urinary incontinence
Order a urine culture for 1 or more
of the following
new CVA tenderness
shaking chills (rigors)
new onset of delirium
¶CVA- Costovertebral angleBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/17
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ing in residential LTCFs (Figure 1 + 2). Since there is no
treatment benefit for asymptomatic bacteriuria
[23,24,26,28], the algorithms indicate that urine should
not be cultured in the absence of fever or urinary symp-
toms, nor should antibiotics be prescribed for positive
cultures. In the absence of any urinary symptoms, only
10% of LTCF residents with fever and bacteriuria actually
have a urinary infection (positive predictive value of urine
culture for urinary infection in the setting of fever is 17%)
(35). Therefore, prior to ordering a culture other common
infections (respiratory or skin and soft tissue) need to be
ruled out. When urinary symptoms are present (in the set-
ting of bacteriuria and fever), about 50% of episodes are,
serologically, urinary infections. Clinical evaluation for
other infections should therefore also be conducted in
such instances prior to instituting antibiotic therapy. A
negative urine culture effectively rules out a urinary infec-
tion (so long as previous antibiotics were not prescribed).
Although bacteriuria in the setting of pyuria is often inter-
preted as a "true infection", studies have shown that over
90% of the institutionalized elderly with bacteriuria also
have pyuria [36,37]. Therefore the presence of pyuria and
bacteriuria is not helpful. However, the absence of pyuria
suggests the absence of a host response (i.e. absence of in-
fection), therefore bacteriuria in the absence of pyuria in-
dicates that a urinary tract infection is unlikely [29]. Gross
hematuria in the institutionalized elderly generally repre-
sents an underlying structural abnormality in the geni-
tourinary tract. About 70% of individuals with gross
hematuria also have bacteriuria [38]. Since as many as
25% of individuals who develop hematuria subsequently
become febrile [38], treatment of the resident with fever,
Figure 2
Treatment algorithm. This algorithm allows physicians and nurses to optimize antibiotic use in residents with suspected infec-
tions.
Treatment Pathway
Results of the urine culture ?
Urinary Catheter ?
1 or more of the following?
new CVA (Costovertebral)
tenderness
shaking chills (rigors)
new onset of delirium
fever**
Is there
new onset burning urination (dysuria) ?
Or 2 or more of the following:
fever**
new or worsening ….
urgency frequency
flank pain gross hematuria
urinary incontinence suprapubic pain
shaking chills
YES
No UTI
NO
Does the resident in my care need antibiotic treatment for a symptomatic UTI?
>1 0 5CFU/mL (positive) OR Pending Negative (no growth or mixed)
If yes, begin antibiotics†
If no, do not treat for UTI † Stop antibiotics if urine culture is negative or no pyuria
Note: the recommended treatment duration for uncomplicated cystitis in women is 7 days and 7-14 in males. For an uncomplicated pyelonephritis, treatment
duration is 10-14 days.For a complicated cystitis, treatment duration is 10 days. For a complicated pyelonephritis, treatment duration is from 14 to 21 days.
** >37.9°C (100 °F) or 1.5°C (2.4 °F) above baseline on 2 occasions over the last 12 hBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/17
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gross hematuria and bacteriuria is necessary due to sec-
ondary invasive infection [39]. Since there is no relation-
ship between the presence or absence of bacteriuria and
non-urinary symptoms [28], only urinary symptoms will
be assessed in the diagnostic or treatment algorithm.
Adoption of the algorithms
The algorithms were pilot-tested in four nursing homes
prior to the start of the actual trial. For the trial, adoption
of the intervention has been through in-services with phy-
sicians and nursing staff using case-scenarios to explain
the use of the algorithms. The algorithms were printed on
pocket cards and distributed to physicians and nursing
staff at the start of the study. The algorithms are also kept
at all nursing stations using large posters. On-site visits are
planned to help with adherence to the protocol.
Data collection
Demographics of the residents and features about the fa-
cilities will be collected. Other data include the name and
dose of the antibiotic, route of administration, start and
stop date, reason for the prescription, as well as urinary
symptoms leading to the prescription, whether a urine
culture was ordered, and if so, its result. Information on
deaths, all cause hospitalizations, and hospitalizations for
urinary sepsis is being collected.
Analysis
The unit of analysis for this study is the nursing home. A
paired t-test will be used to analyse the within-pair differ-
ences between the proportions of antibiotics prescribed
for urinary indications in matched pairs of nursing
homes. In this way, the fact that the denominator of the
proportions is also an outcome is taken into considera-
tion. Differences in rates of overall antibiotic use (antibi-
otic courses per 1000 resident days) will be compared
using a paired t-test. Rates of antibiotic use for urinary in-
dications (antibiotic courses per 1000 resident days and
defined daily dosages/1000 resident days), rates of urine
cultures obtained (urine cultures per 1000 resident days),
rates of hospitalization (per 1000 resident days), and
overall mortality rates will be compared using paired t-
tests and Wilcoxon signed rank tests. Logistic regression
analysis is planned to account for potentially important
co-variates such as proportion of residents bed/wheel-
chair bound and pharmacy automatic stop dates [40].
Sample size calculation
In our 12 month study of antibiotic utilization in Ontario
long-term care facilities, 30% of all antibiotic prescrip-
tions were for urinary indications, of which one third were
for asymptomatic bacteriuria. We believe that the algo-
rithm will lead to at least a 20% reduction in the overall
use of antibiotics, that is, a reduction in the proportion of
antibiotic prescriptions for urinary indications from 30%
to 10%. To detect this difference, for an alpha of 0.05 and
80% power, a total of 142 prescriptions (71 in each arm)
is needed. To adjust for the effect of within cluster depend-
ency, the intracluster correlation coefficient (between
home variance for urinary antibiotic prescription / sum of
inter- and intra-home variance), was then calculated using
data from the 12 month study in Ontario long-term care
facilities. The proportion of antibiotics prescribed for a
urinary indication was 0.32 (p) and the variance 0.009
(between home variance). The intra-home variance, given
by the binomial distribution [(p) (1-p)], was 0.21. There-
fore, the intracluster correlation coefficient is 0.04. Don-
ner et al. (41) describe a variance inflation factor given by
1 + (n - 1) , where  is the intracluster correlation coeffi-
cient, and n= samples (prescriptions) needed per cluster.
Since 23 prescriptions can be obtained per home per
month (based on the average LTCF in our Canada-US
study), and if data collection is conducted over 11
months, then n = 253. Using the formula given above, the
variance inflation factor is 11. Therefore, 1562 (142  11)
urinary prescriptions are required. Since these represent
30% of antibiotic prescriptions, 5206 prescriptions need
to be collected in total. This means that 20 or 10 pairs of
nursing homes will need to be followed for 12 months.
Since matching, which would improve efficiency, was not
accounted for in the sample size calculation, these figures
are a conservative estimate. We will recruit another two
homes to maintain the target sample size in case a pair of
homes withdraws from the study.
Qualitative component
To evaluate the process of adopting the proposed algo-
rithms in LTCFs, we plan to conduct focus groups and
semi-structured interviews. Two groups of respondents
will be interviewed, key clinical administrators in the par-
ticipating LTCFs (medical directors, directors of nursing,
infection control officers), and staff who will implement
the algorithms (RN and RPN). Standard methods to en-
sure that the qualitative data are gathered and analyzed
rigorously will be followed throughout the study. These
include member checking (asking respondents to review
our findings), peer review (asking colleagues to review our
research process), and an audit trail (creating documents
which outline all decisions made throughout the investi-
gation) [42]. Each of these steps will be taken in this study
to ensure that this portion of the study is rigorous and
findings are trustworthy.
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